Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

The long-term aim is to develop a nontoxic and effective vaccine that defends people worldwide after getting infected with HIV. However, even if a vaccine only defends some people who get vaccinated, or even if it affords less than total protection by reducing the threat of infection, it could still have a major impact on the rates of transmission and help control the pandemic, particularly for populations at high risk of HIV infection. A partially effective vaccine could decrease the number of people who get infected with HIV, further reducing the number of people who can pass the virus on to others. By considerably reducing the number of new-fangled infections, we can stop the widespread.

  • Track 1-1HIV Vaccine Strategies
  • Track 1-2T cell-based Vaccines
  • Track 1-3B cell-based Vaccines
  • Track 1-4Innate & Mucosal Immunity
  • Track 1-5Viral Vaccine Vectors

The principal course of rabies treatment was controlled under the supervision of Louis Pasteur, over a century back. From that point forward, rabies immunizations have dependably been among the first to profit by advance underway and control. As respects immunizations for human use, around 1955 there was a change from antibodies arranged from creature nerve tissue to embryonated eggs and soon a short time later, around 1960, to adjustment of rabies infection to societies of human diploid cells. The improvement of this antibody, which remains the reference immunization in relative investigations of immunogenicity, took long years. It was first enlisted in France in 1974 and somewhat later in North America. The late 1970s and the 1980s saw the advancement of a plenty of immunizations arranged on different cell substrates, for example, essential explant cells of hamster, canine or fetal calf kidney, fibroblasts of chicken developing life, or diploid cells from rhesus monkey fetal lung, lastly cells from nonstop lines (Vero cells). The creation of some of these immunizations was ceased toward the finish of the 1980s while others have been controlled to a huge number of patients.

  • Track 2-1Meningococcal /Menactra Vaccines
  • Track 2-2Smallpox Vaccine
  • Track 2-3Rotavirus Vaccine
  • Track 2-4Tuberculosis Vaccine
  • Track 2-5Bordetella Vaccine
  • Track 2-6OPV (Oral Poliovirus Vaccine)
Immunization is an imperative piece of the family and general wellbeing. Immunizations keep the spread of infectious, unsafe, and even fatal ailments. These incorporate measles, polio, mumps, chicken pox, challenging hack, diphtheria, and HPV. The primary genuine immunization found was the smallpox antibody. Smallpox was a lethal sickness a century prior. It slaughtered 300 million to 500 million individuals around the globe in the twentieth century alone. The immunization was given to numerous individuals. The malady was in the end deleted from the earth. It is the main malady to be totally obliterated. There are presently others near that point. These incorporate polio and mumps. Without the smallpox antibody, numerous more individuals would definitely kick the bucket. Rather, we don't should be inoculated for it any longer. This is the thing that immunizations can do.
  • Track 3-1Routes of Administration
  • Track 3-2Opposition to Vaccination
  • Track 3-3Adult immunization
  • Track 3-4Travel immunizations

An antibody preventable sickness is an irresistible malady for which a compelling preventive immunization exists. On the off chance that a man procures an immunization preventable ailment and passes on from it, the demise is viewed as an antibody preventable passing.

  • Track 4-1pneumococcal infections
  • Track 4-2Rubella
  • Track 4-3Pertussis (whooping cough)
  • Track 4-4Typhoid
  • Track 4-5Japanese encephalitis
  • Track 4-6bat lyssavirus
  • Track 4-7varicella-zoster (chickenpox)

The main objectives of veterinary immunizations are to advance the wellbeing and welfare of companion creatures, increment making of domesticated animals in a sparing way, and stay away from creature to-human transmission from together local creatures and untamed life. These diverse points have assimilated to assorted strategies to the advance of veterinary antibodies from unrefined in the past valid entire pathogen arrangements to molecularly unmistakable subunit immunizations, on a very basic level built animals previously figments, vectored antigen definitions, other than stark-bare DNA infusions. The last productive result of antibody examination and improvement is the age of an item that will be available in the commercial centre or that will be utilized as a part of the field to achieve wanted results. As itemized in this survey, fruitful veterinary antibodies have been delivered in inconsistency of viral, bacterial, protozoal, and multicellular pathogens, which in numerous behaviours have driven the field in the application and variety of novel advancements. These veterinary immunizations have devoured, and keep on having, a noteworthy effect on creature prosperity and generation as well as on human wellbeing through expanding innocuous nourishment supplies and anticipating creature to-human communicate of irresistible infections. The proceeded with connection amongst creatures and human analysts and wellbeing experts will be of real significance for acquainting new advancements, giving creature models of ailment, and undermining new and developing irresistible infections.

  • Track 5-1Vaccines for Livestock Diseases
  • Track 5-2Advances in Veterinary Vaccines
  • Track 5-3Types of Veterinary Vaccines

As new advancements and customized antibodies turn into the standard, the dynamic of clinical preliminaries needs to develop. This engaged clinical advancement meeting will enable you to exhibit your administrations to the individuals who are hoping to run new preliminary models, require bolster in picking and picking up endorsement for various clinical endpoints and need to see how to get the best out of the data gathered.

  • Track 6-1Exploratory Stage
  • Track 6-2Pre-clinical Stage
  • Track 6-3Clinical development
  • Track 6-4Manufacturing
  • Track 6-5Quality Control

For the past two centuries, vaccines have provided a safe and effective means of preventing a number of infectious diseases. Although the safety of some vaccines has been questioned in recent years, the currently available vaccines are more than a millionfold safer than the diseases they are designed to prevent. Vaccines, however, should always be used in conjunction with other public health interventions. One important intervention is education because the general public can be led to believe that vaccines are unsafe and not needed by misinformation readily available electronically and in print. Not only are some vaccines available via injection but other vaccines are also given orally or intranasally. New vaccines are being studied for topical and intravaginal use. In addition, new systems are being developed for more efficient production of vaccines, especially for influenza. Vaccines are currently available for only a limited number of viral and bacterial diseases. In the future, it is anticipated that safe and effective vaccines will be developed against a number of other viral and bacterial infections as well as fungal and protozoan diseases.

  • Track 7-1Factors Influencing Vaccine efficacy
  • Track 7-2Patient and Public acceptance and perceptions
  • Track 7-3Vaccine safety communication
  • Track 7-4Vaccine Safety Monitoring and Vaccine Pharmacovigilance

Antibody Research and Development includes immunization investigate in the field of irresistible maladies in the aggregate reconciliation, including growth, AIDS and allergies. New immunizations are always being looked into and created. There has been a relentless movement in the progression of immunizations that has prompted advancement of authorized vaccines. Combination antibodies have been presented which can keep a few illnesses immediately. Hazard profile of antibody against unending maladies is modestly high when contrasted with those against intense infections.

  • Track 8-1End-to-End Product Development
  • Track 8-2Bioprocess Development
  • Track 8-3Antigen Presentation Technology
  • Track 8-4Adjuvant Technologies
  • Track 8-5Viral Vector Technology
  • Track 8-6Pathogen Surveillance
  • Track 8-7Antibody Technology
  • Track 8-8Novel Vaccine Delivery

With such a great amount of action around disease antibodies and immunotherapy at this moment, would you be able to bear to pass up a major opportunity? It is where the worldwide market will meet up to share the most recent in beginning time logical headways, present clinical preliminary information, talk about new plans of disease immunizations and evaluate the fate of blend medications. Ensure that individuals know about the work you are doing to put yourself at the front line of the business.

  • Track 9-1Monoclonal antibodies to treat cancer
  • Track 9-2CAR T-Cell Therapy to Treat Cancer
  • Track 9-3Non-specific cancer immunotherapies and adjuvants
  • Track 9-4Immune Checkpoint Inhibitors and Cytokines

Mucosal tissues (e.g. nasal, oral, visual, rectal, vaginal) cover an extensive surface of the body. It is basic to create methodologies for killing the irresistible specialist at these surfaces since contaminations are started at these destinations. Mucosal inoculation includes the organization of immunizations at least one mucosal locales prompting enlistment of insusceptible reactions at that site, or other mucosal destinations. Vaccination includes the conveyance of antigens to the mucosal invulnerable framework. The antigen conveyance frameworks may involve a straightforward support arrangement with/without adjuvants or a propelled particulate detailing, for example, liposomes or nanoparticles. The most normally assessed course for mucosal antigen conveyance is oral, however different courses have additionally been investigated.

  • Track 10-1Mucosal Antigens
  • Track 10-2Mucositis
  • Track 10-3Sinus Mucosal
  • Track 10-4Lichinoid Mucositis
  • Track 10-5Common Vaccination given by Mucosal Route

The influenza vaccine is a yearly vaccine that protects you from getting the flu, a viral respiratory illness that spreads very easily. The flu can lead to serious health complications and possibly death. The best way to prevent the flu is to get vaccinated


  • Track 11-1 live attenuated influenza vaccine (LAIV)
  • Track 11-2Influenza type A or B
  • Track 11-3Vaccines for Routine and Selective uses
  • Track 11-4Quadrivalent Influenza Vaccine

Immunization is the process whereby a person is made resistant to an infectious disease, typically usually by the administration of a vaccine. The agent in a vaccine stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it. In this way, the immune system can more easily recognize and destroy any of these microorganisms in future encounters.


  • Track 12-1Live virus vaccine
  • Track 12-2Killed (inactivated) vaccines
  • Track 12-3Toxoid vaccines
  • Track 12-4Biosynthetic vaccines

vaccination plays an important part in the health management of the poultry flock. There are numerous diseases that are prevented by vaccinating the birds against them. A vaccine helps to prevent a particular disease by triggering or boosting the bird’s immune system to produce antibodies that in turn fight the invading causal organisms.

  • Track 13-1Avian Encephalomyelitis
  • Track 13-2Newcastle Disease Vaccine
  • Track 13-3Newcastle-Bronchitis
  • Track 13-4MG-Bac Vaccine

Hepatitis brings liver inflammation, and it can be serious or even life-threatening. There are safe and effective vaccines that can prevent hepatitis A and B (but not for types C, D, or E). There is also a combination vaccine that guard’s against hep A and B.


  • Track 14-1Hepatitis A and B
  • Track 14-2Hepatitis A
  • Track 14-3Hepatitis B
  • Track 14-4Hepatitis C
  • Track 14-5Hepatitis D

Plant-based Vaccines. Plant-based vaccines are recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oral drug delivery in the form of an edible vaccine.


  • Track 15-1Plastid transformation
  • Track 15-2Plant Viral Vector
  • Track 15-3Agro Bacterium Primary Vector
  • Track 15-4Infiltration of Agrobacterium
  • Track 15-5Challenges of plant based vaccines

The immunisation supply chain encompasses all the people, activities, infrastructure, resources and planning necessary to ensure that vaccines stay safe and effective and reach the children who need them. Strong supply chains are a prerequisite to improving immunisation coverage and equity, and they contribute to reduced child mortality.


  • Track 16-1The Vaccine Alliance Solution
  • Track 16-2Vaccine management and logistics support
  • Track 16-3Controlled temperature chain (CTC)
  • Track 16-4Effective Vaccine Management (EVM) Initiative
  • Track 16-5TechNet-21

Aquaculture has been globally recognized as the fastest growing food production sector (FAO). The intensive farming of finfishes and shellfishes has led to an imbalance of optimal culture conditions, which shows increased susceptibility to infectious disease. Increased incidence of microbial diseases in aquaculture system is the major obstacle in the success of the industry. Use of antibiotics has attracted lot of criticism due to the issues like antibiotic residues, bacterial drug resistance and toxicity. In this present scenario, vaccination would be the best alternative to combat bacterial and viral disease for the sustainable aquaculture. The first report on fish vaccination was by David C. B.

  • Track 17-1 Dead vaccines
  • Track 17-2Live vaccines
  • Track 17-3Injection Vaccination
  • Track 17-4Immersion Vaccination
  • Track 17-5Spray Vaccination
  • Track 17-6Oral vaccination

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. This review summarizes current literature data on vaccine safety and efficacy in IMID patients treated with immunosuppressive or immunomodulatory drugs and formulates best-practice recommendations on vaccination in this population. Especially in the current era of biological therapies, including TNF-blocking agents, special consideration should be given to vaccination strategies in IMID patients


  • Track 18-1Vaccines for immunodeficiency diseases
  • Track 18-2Vaccines for autoimmune skin disorders & neuropathies
  • Track 18-3 Impact on disease activity in IMID patients
  • Track 18-4Innate immunity and diabetes vaccines

Vaccines help protect you and your baby against serious diseases. You probably know that when you are pregnant, you share everything with your baby. That means when you get vaccines, you aren’t just protecting yourself—you are giving your baby some early protection too. CDC recommends you get a whooping cough and flu vaccine during each pregnancy to help protect yourself and your baby.


  • Track 19-1Flu (influenza) shot
  • Track 19-2Tetanus toxoid
  • Track 19-3Tdap (Pertussis) Vaccine
  • Track 19-4MMR vaccine
  • Track 19-5HPB, HAV, HBV vaccination for neonates

A recombinant vaccine is a vaccine produced through recombinant DNA technology. This involves inserting the DNA encoding an antigen (such as a bacterial surface protein) that stimulates an immune response into bacterial or mammalian cells, expressing the antigen in these cells and then purifying it from them.


  • Track 20-1Subunit recombinant vaccines
  • Track 20-2Attenuated recombinant vaccines
  • Track 20-3Vector recombinant vaccines